Clinical role of cervical cancer vaccination: When and whom to vaccinate?

Gynecologic Oncology

Volumn 110, Issue 3 SUPPL.2, 2008, Pages

  Torné, Aureli ^a   Alonso, Immaculada ^a   Puig Tintoré, Luis M ^a   Pahisa, Jaume ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ANTIBODY TITER; ARTICLE; CANCER IMMUNIZATION; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRECANCER; PRIORITY JOURNAL; SEXUALITY; TREATMENT CONTRAINDICATION; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 50049090570     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.06.015     Document Type: Article

References (10)

1. Ferlay F., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002: cancer incidence. Mortality and prevalence worldwide. IARC CancerBase No 5, Version 2.0. (2004), IARC Press, Lyon
2. Merck Research Laboratories. GardasilÒ (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine). Vaccines and related biological products advisory committee (VRBPAC) briefing document. Presented to VRBPAC on May 18, 2006. Rockville, MD: US Food and Drug Administration, 2006. http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4222B1.pdf (accessed December 21, 2006).
3. Brown D.R., Shew M.L., Qadadri B., Neptune N., Vargas M., Tu W., Juliar B.E., Breen T.E., and Fortenberry J.D. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J. Infect. Dis. 191 (2005) 182-192
4. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., and Koutsky L.A. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157 (2003) 218-226
5. Smith E.M., Johnson S.R., Ritchie J.M., Feddersen D., Wang D., Turek L.P., and Haugen T.H. Persistent HPV infection in postmenopausal age women. Int. J. Gynaecol. Obstet. 87 (2004) 131-137
6. Wellings K., Collumbien M., Slaymaker E., Singh S., Hodges Z., Patel D., and Bajos N. Sexual behaviour in context: a global perspective. Lancet 368 (2006) 1706-1728
7. De Sanjose S., Cortés J., Mendez C., Puig-Tintoré L.M., Torne A., Roura E., Castellsague X. Age at sexual initiation and number of sexual partners in the female Spanish population. Results from the AFRODITA survey. Eur J Obstet and Gynecol and Reprod Biol 2008; in press.
8. Wright T.C., and Bosch F.X. Is viral status needed before vaccination?. Vaccine 26S (2008) A12-A15
9. Frazer I.H. HPV vaccines. Int J Gynecol Obst 94 (2006) S81-S88
10. Palefsky J.M., Gillison M.L., and Strickler H.D. HPV vaccines in immunocompromised women and men. Vaccine 24S3 (2006) 152-159